Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray D Page

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Oncology Practice|April 13, 2018
Impact on Oncology Practices of Including Drug Costs in Bundled PaymentsJeffery C Ward, Laura A Levit, Ray D Page, et al.
Journal of Oncology Practice|March 19, 2019
Implementing an Electronic End-of-Life Chemotherapy Utilization MeasureJoshua Kraut, Kathi Mooney, John W Sweetenham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung CancerNatasha B Leighl, Ray D Page, Victoria M Raymond, et al.
JCO Oncology Practice|June 21, 2021
Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task ForceFay J Hlubocky, Anthony L Back, Tait D Shanafelt, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2011
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerRadj Gervais, John D Hainsworth, Normand Blais, et al.
JCO Oncology Advances|February 5, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023Caroline Schenkel, Laura A Levit, Kelsey Kirkwood, et al.
JCO Oncology Practice|July 28, 2021
Telehealth in Oncology: ASCO Standards and Practice RecommendationsRobin T Zon, Erin B Kennedy, Kerin Adelson, et al.
Clinical Lung Cancer|November 16, 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung CancerRay D Page, Leylah M Drusbosky, Hiba Dada, et al.
Lung Cancer (Auckland, N.Z.)|November 16, 2017
<i>nab</i>-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapyMichael Thomas, David R Spigel, Robert M Jotte, et al.
The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Oncology Practice|April 13, 2018
Impact on Oncology Practices of Including Drug Costs in Bundled PaymentsJeffery C Ward, Laura A Levit, Ray D Page, et al.
Journal of Oncology Practice|March 19, 2019
Implementing an Electronic End-of-Life Chemotherapy Utilization MeasureJoshua Kraut, Kathi Mooney, John W Sweetenham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung CancerNatasha B Leighl, Ray D Page, Victoria M Raymond, et al.
JCO Oncology Practice|June 21, 2021
Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task ForceFay J Hlubocky, Anthony L Back, Tait D Shanafelt, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2011
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerRadj Gervais, John D Hainsworth, Normand Blais, et al.
JCO Oncology Advances|February 5, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023Caroline Schenkel, Laura A Levit, Kelsey Kirkwood, et al.
JCO Oncology Practice|July 28, 2021
Telehealth in Oncology: ASCO Standards and Practice RecommendationsRobin T Zon, Erin B Kennedy, Kerin Adelson, et al.
Clinical Lung Cancer|November 16, 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung CancerRay D Page, Leylah M Drusbosky, Hiba Dada, et al.
Lung Cancer (Auckland, N.Z.)|November 16, 2017
<i>nab</i>-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapyMichael Thomas, David R Spigel, Robert M Jotte, et al.
The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.
Pageof 4